Supplementary file 1_Hard to jump: host shifts appear unlikely in a T4-like phage evolved in the lab.docx

Supplementary file 1_Hard to jump: host shifts appear unlikely in a T4-like phage evolved in the lab.docx

Introduction<p>Bacteriophage therapy is emerging as a promising alternative to antibiotics, particularly in the face of rising antimicrobial resistance. However, concerns remain regarding host shifts, where therapeutic phages could evolve to infect and harm beneficial commensal bacteria. Under...

保存先:

書誌詳細
第一著者:	Yu Ning (588573) (author)
その他の著者:	Enrique González-Tortuero (3514427) (author), Jeroen Wagemans (1743634) (author), Flor I. Arias-Sánchez (7329746) (author)
出版事項:	2025
主題:	Clinical Microbiology phage therapy host shifts virulence infection phage therapeutics
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Table 1_Hard to jump: host shifts appear unlikely in a T4-like phage evolved in the lab.xlsx
著者:: Yu Ning (588573)
出版事項: (2025)

Additional file 2 of Characterization of a novel Jumbo phage JP4 with potential to control pathogenic Escherichia coli
著者:: Kexin Zhang (301752)
出版事項: (2025)

Lab Materials
著者:: Rebecca Cree (19974267)
出版事項: (2025)

Table 1_Novel integrated approach modeling proanthocyanidins and bacteriophages to combat multidrug Salmonella Typhimurium in challenged broilers.docx
著者:: Hanan S. Al-Khalaifah (12864938)
出版事項: (2025)

Primers Used in This Study.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Bacterial Strains and Plasmids Used in This Study.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Oxidative stress resistance of the <i>yqhG</i> mutant.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Quantification of cell-associated PSMs in wild-type, Δ<i>yqhG</i>, and complemented strains. Cell-associated PSMs were extracted from bacterial pellets using 6 M guanidine hydrochloride and quantified by reversed-phase HPLC. The Δ<i>yqhG</i> mutant exhibited a significant reduction in surface-bound PSMs compared with the wild-type strain, whereas complementation restored PSM levels to near wild-type values. Data represent mean ± s.e.m. from three independent experiments. Statistical analysis was performed using one-way ANOVA; *<i>P</i> < 0.05, ns, not significant.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Surface motility of the <i>yqhG</i> mutant.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Membrane integrity in the <i>yqhG</i> mutant.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Biofilm formation in MRSA strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

YqhG is required for systemic virulence but not for <i>in vitro</i> growth.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Viable CFU counts following hydrogen peroxide exposure.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Amount of PSMs (μg/1mL culture) in MRSA wild-type, ΔyqhG, and complemented strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Colony diameter measurements from soft agar motility assays.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

SYTOX Green fluorescence measurements for membrane permeability assessment.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Crystal violet quantification of biofilm formation in MRSA wild-type, ΔyqhG, and complemented strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Spleen bacterial burden in mice infected with MRSA wild-type, ΔyqhG, and complemented strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Liver bacterial burden in mice infected with MRSA wild-type, ΔyqhG, and complemented strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Kidney bacterial burden in mice infected with MRSA wild-type, Δ<i>yqhG</i>, and complemented strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Heart bacterial burden in mice infected with MRSA wild-type, Δ<i>yqhG</i>, and complemented strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Survival data of BALB/c mice infected with MRSA wild-type, Δ<i>yqhG</i>, and complemented strains.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Optical density measurements of MRSA wild-type, Δ<i>yqhG</i>, and complemented strains during <i>in vitro</i> growth.
著者:: Jianhua Liao (1393228)
出版事項: (2025)

Identification of Septoria Nodorum Blotch Sensitivity Genes in Hard Winter Wheat: MS thesis - Oklahoma State University
著者:: Meriem Aoun (16325814)
出版事項: (2025)

Table 1_Effects of resisted sprint training on sprint, jump, and change-of-direction performance in athletes: a systematic review and meta-analysis.docx
著者:: Chengcheng Li (2591632)
出版事項: (2025)

Shifting the Narrative; Changing the World
著者:: Roselyn Berry (22676237)
出版事項: (2025)

Evaluating docking approaches for prediction of cyclodextrin and cucurbituril host–guest complex structures
著者:: N.-F.J. Ettema (22683726)
出版事項: (2025)

Transcriptomic profiling of HIOs reveals viral replication and distinct host responses to EBOV and MARV infection.
著者:: Elizabeth Y. Flores (22676699)
出版事項: (2025)

<b>No effect of actual parasitism risk on egg rejection in two sympatric breeding cuckoo hosts</b>
著者:: Hanlin Yan (19840763)
出版事項: (2025)

Transcriptomic profiling of EBOV- and MARV-infected HCOs reveals viral load and shared and unique host responses.
著者:: Elizabeth Y. Flores (22676699)
出版事項: (2025)

Data phase shift for direct beam entering the interferometer
著者:: Stalin Beltran (22512557)
出版事項: (2025)

Data Sheet 1_An evolving role in the NICU: a study of the tasks, knowledge, skills, and practice demographics of the neonatal therapist.pdf
著者:: Alicia Fernandez-Fernandez (9139193)
出版事項: (2025)

Finland Confirms Historic Shift to Online Gambling License System by 2027
著者:: Tommi Korhonen (22683659)
出版事項: (2025)

Data Sheet 1_Interactions between the oyster larvae pathogen Vibrio ostreicida and the bivalve hosts Mytilus galloprovincialis and Magallana gigas.docx
著者:: Martina Leonessi (22686236)
出版事項: (2025)

Time series of concentration, best cross-correlation and shift of two stations at the Starzach site.
著者:: Yann Georg Büchau (22683667)
出版事項: (2025)

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S5 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_j9gst3tk3a299hib9lbfnufd8v